Ocular drug delivery is challenging due to the presence of anatomical and physiological
barriers. These barriers can affect drug entry into the eye following multiple routes of …

Alzheimer's disease is a neurological disorder that results in cognitive and behavioral
impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs …

Nanostructured lipid carrier (NLC) is second generation smarter drug carrier system having
solid matrix at room temperature. This carrier system is made up of physiological …

Anatomy and physiology of the eye makes it a highly protected organ. Designing an effective
therapy for ocular diseases, especially for the posterior segment, has been considered as a …

The present review deals with the progress of Polysorbates (Tween) based microemulsions
in drug delivery. PEGylated Sorbitan Fatty Acid Esters (Tweens/Polysorbates) are one of the …

Solid lipid-based nanoparticles (SLBNs) were developed as potential alternatives to other
conventional drug delivery systems such as polymeric nanoparticles, liposomes, and …

Topical ocular drug delivery has been considered to be an ideal route of administration for
treatment of ocular diseases related to the anterior segment of the eye. However, topical …

The eyes are among the most readily accessible organs in terms of location in the body, yet
drug delivery to eye tissues is particularly problematic. Poor bioavailability of drugs from …

The objective of the present investigation was to explore the potential of the Chitosan
Oligosaccharides (COS)-coated NLC (nanostructured lipid carrier) for ocular drug delivery …

In this study liposome coated with low molecular weight chitosan (LCH) was proposed and
investigated its in vitro and in vivo properties, and its potential use in ocular drug delivery …